Literature DB >> 11281456

Back mutation can produce phenotype reversion in Bloom syndrome somatic cells.

N A Ellis1, S Ciocci, J German.   

Abstract

A unique and constant feature of Bloom syndrome (BS) cells is an excessive rate of sister-chromatid exchange (SCE). However, in approximately 20% of persons with typical BS, mosaicism is observed in which a proportion of lymphocytes (usually a small one) exhibits a low-SCE rate. Persons with such mosaicism predominantly are genetic compounds for mutation at BLM, and the low-SCE lymphocytes are the progeny of a precursor cell in which intragenic recombination between the two sites of BLM mutation had generated a normal allele. Very exceptionally, however, persons with BS who exhibit mosaicism are homozygous for the causative mutation. In two such exceptional homozygous persons studied here, back mutation has been demonstrated: one person constitutionally was homozygous for the mutation 1544insA and the other for the mutation 2702G-->A. Revertant (low-SCE) lymphoblastoid cells in each person were heterozygous for their mutations, i.e., a normal allele was now present. The normal alleles must have arisen by back mutation in a precursor cell, in one person by the deletion of an A base and, in the other, the nucleotide substitution of a G base for an A base. Thus, back mutation now becomes, together with intragenic recombination, an important genetic mechanism to consider when explaining examples of a reversion of somatic cells to "normal" in persons with a genetically determined abnormal phenotype.

Entities:  

Mesh:

Year:  2001        PMID: 11281456     DOI: 10.1007/s004390000447

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  16 in total

Review 1.  Induced pluripotent stem cells in dermatology: potentials, advances, and limitations.

Authors:  Ganna Bilousova; Dennis R Roop
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

2.  Revertant somatic mosaicism by mitotic recombination in dyskeratosis congenita.

Authors:  Marjolijn C J Jongmans; Eugene T P Verwiel; Yvonne Heijdra; Tom Vulliamy; Eveline J Kamping; Jayne Y Hehir-Kwa; Ernie M H F Bongers; Rolph Pfundt; Liesbeth van Emst; Frank N van Leeuwen; Koen L I van Gassen; Ad Geurts van Kessel; Inderjeet Dokal; Nicoline Hoogerbrugge; Marjolijn J L Ligtenberg; Roland P Kuiper
Journal:  Am J Hum Genet       Date:  2012-02-16       Impact factor: 11.025

3.  The Rules of Variation Expanded, Implications for the Research on Compatible Genomics.

Authors:  Fernando Castro-Chavez
Journal:  Biosemiotics       Date:  2011-05-12       Impact factor: 0.711

Review 4.  Physiological consequences of defects in ERCC1-XPF DNA repair endonuclease.

Authors:  Siobhán Q Gregg; Andria Rasile Robinson; Laura J Niedernhofer
Journal:  DNA Repair (Amst)       Date:  2011-05-25

Review 5.  Bloom's Syndrome: Clinical Spectrum, Molecular Pathogenesis, and Cancer Predisposition.

Authors:  Christopher Cunniff; Jennifer A Bassetti; Nathan A Ellis
Journal:  Mol Syndromol       Date:  2016-11-05

6.  Regional genomic instability predisposes to complex dystrophin gene rearrangements.

Authors:  Junko Oshima; Daniel B Magner; Jennifer A Lee; Amy M Breman; Eric S Schmitt; Lisa D White; Carol A Crowe; Michelle Merrill; Parul Jayakar; Aparna Rajadhyaksha; Christine M Eng; Daniela del Gaudio
Journal:  Hum Genet       Date:  2009-05-16       Impact factor: 4.132

Review 7.  In vivo reversion to normal of inherited mutations in humans.

Authors:  R Hirschhorn
Journal:  J Med Genet       Date:  2003-10       Impact factor: 6.318

8.  Genetic and clinical mosaicism in a patient with neurofibromatosis type 1.

Authors:  Ina Vandenbroucke; Remco van Doorn; Tom Callens; Jan M Cobben; Theo M Starink; Ludwine Messiaen
Journal:  Hum Genet       Date:  2003-11-06       Impact factor: 4.132

Review 9.  New approaches to treatment of primary immunodeficiencies: fixing mutations with chemicals.

Authors:  Hailiang Hu; Richard A Gatti
Journal:  Curr Opin Allergy Clin Immunol       Date:  2008-12

Review 10.  Somatic genetic rescue in Mendelian haematopoietic diseases.

Authors:  Patrick Revy; Caroline Kannengiesser; Alain Fischer
Journal:  Nat Rev Genet       Date:  2019-06-11       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.